Depression treatment with behavioral activation: a meta-analysis of 105 randomized trials

This systematic review and meta-analysis examined 105 randomized trials comparing behavioral activation for depression with control groups and other treatments.

An empty therapy room with two armchairs, a coffee table, house plants, bookshelves and a coat rack.
Illustration

What the study found

The authors reviewed 105 randomized trials covering 13,933 patients with depression, and 40 of those trials had low risk of bias. Sixty-four of the programs were delivered one to one, and the mean number of sessions was 9. Across 61 comparisons in adult outpatients, behavioral activation reduced depression scores by 0.67 standardized units compared with control conditions. Results varied widely across the 61 outpatient comparisons, with 71% of the variation reflecting real differences between studies rather than chance. In adult outpatient trials, an estimated 34% with behavioral activation and 16% under control conditions had symptoms reduced by at least half. In adult outpatient trials, dropout for any reason was 17% with behavioral activation, compared with 13% under control conditions. In adult outpatients, the advantage over control conditions was significant at 6 and at 9 to 12 months after randomization, not between 6 and 9. Across 27 direct comparisons, the team found no statistically significant difference in depression scores between behavioral activation and other psychotherapies. Self-guided behavioral activation without therapist support reduced depression scores by 0.36 standardized units across 15 trials compared with control conditions. Across 10 trials in institutional settings, behavioral activation reduced depression scores by 0.36 standardized units compared with control conditions. Only 4 trials studied children and adolescents and 4 compared behavioral activation with medication, which was too few to estimate effects. Among 661 psychotherapy comparisons with control groups, effects did not differ significantly between therapies with and without behavioral activation as a component. The authors conclude that behavioral activation is efficacious for depression in adults, with a significant effect up to 12 months after randomization.

Limits of this study

Wide variation in results between studies could not be completely explained by removing outliers or testing study characteristics. Because expected outcomes across populations span below zero, some future trials of behavioral activation may find negative effects. More than 60% of included trials had some risk of bias, and in several subsets, trials at low risk of bias showed smaller effects. Indications of publication bias in several analyses mean the overall effects of behavioral activation may have been overestimated. Relatively few randomized trials have examined the effects of behavioral activation beyond 12 months after randomization.

What this means in Nepal

A 2022 WHO assessment states that primary care in Nepal is meant to manage depression, where behavioral activation could be tested. A 2022 WHO assessment estimates about 700 public sector lay counsellors in Nepal, who might deliver structured behavioral activation if trained. The National Mental Health Survey 2020 found that 23% of adults with a mental disorder sought treatment, so self-guided tools might widen access.

Related reading

More from Global Psy Updates

Find your way around psynepal.org

Also from PsyNepal: Master · Entrance · Self-checks · BMR · How they fit together

Need help now? Call 1166, free, 24 hours. More helplines